步长制药：全资子公司完成工商变更登记

Core Viewpoint - Company announced a change in the business scope of its wholly-owned subsidiary, Yangling Buchang Pharmaceutical Co., Ltd., to meet operational management needs [2] Group 1 - The fifth meeting of the fifth board of directors is scheduled for November 7, 2025, to review the proposal for the change in business scope [2] - Yangling Buchang has completed the industrial and commercial change registration procedures and obtained a new business license from the Yangling Demonstration Zone Market Supervision Administration [2]